Rachael Coleman

Pulmonary function and survival one year after dupilumab treatment of acute moderate to severe COVID-19: A follow up study from a Phase IIa trial

H. Haughey, U. Nayak, J. Sturek, 2023, medRxiv.

Pulmonary Function and Survival 1 Year After Dupilumab Treatment of Acute Moderate to Severe Coronavirus Disease 2019: A Follow-up Study From a Phase 2a Trial

J. Allen, Uma Nayak, Jennifer Hendrick, 2024, Open Forum Infectious Diseases.